Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 9,395 |
|
|||||
| News | - | ||||||
| Day High | 6.70 | Low High |
|||||
| Day Low | 6.5976 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fennec Pharmaceuticals Inc | FENC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 0.60% | 6.69 | 09:15:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.62 | 6.5976 | 6.70 | 6.65 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 204 | 9,395 | US$ 6.62 | US$ 62,232 | - | 6.30 - 11.92 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:14:53 | 10 | US$ 6.69 | USD |
Fennec Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 242.63M | 26.63M | - | 21.25M | -16.05M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fennec Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FENC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.91 | 6.985 | 6.5976 | 6.78 | 95,852 | -0.22 | -3.18% |
| 1 Month | 7.08 | 7.31 | 6.58 | 6.87 | 110,789 | -0.39 | -5.51% |
| 3 Months | 11.20 | 11.37 | 6.51 | 8.28 | 155,392 | -4.51 | -40.27% |
| 6 Months | 10.10 | 11.92 | 6.51 | 9.22 | 134,660 | -3.41 | -33.76% |
| 1 Year | 9.40 | 11.92 | 6.30 | 8.85 | 123,845 | -2.71 | -28.83% |
| 3 Years | 6.55 | 11.92 | 3.8219 | 7.98 | 103,899 | 0.14 | 2.14% |
| 5 Years | 3.97 | 11.92 | 3.67 | 7.59 | 117,061 | 2.72 | 68.51% |
Fennec Pharmaceuticals Description
| Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. |
